Direct C7‐H Arylation of Pyrazolo[1,5‐ a ]azines with Aryl Chlorides
Chemistry – A European Journal · 10.08.2023 · 29 (45)
DOI: 10.1002/chem.202301485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 07.07.2023. Verfasst von Thanh V Q Nguyen. Beteiligte Einrichtung: Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
C7‐Arylated pyrazolo[1,5‐ a ]azines are important structural motifs with profound applications in drug and material research. Here, we report a general and straighforward synthesis of these bi(hetero)aryls via palladium‐catalyzed direct C−H arylation, employing low‐cost and abundant (hetero)aryl chlorides as the aryl source. The catalytic system is robust and covers a wide substrate scope regarding heteroarenes as well as (hetero)aryl chlorides, with possible extension to the C−H arylation of [1,2,4]triazolo[1,5‐ a ]pyrimidines. This study also presents a rare example of using (hetero)aryl chlorides for the direct C−H arylation of six‐membered heteroarenes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Zitieren
APA
Nguyen, T. V. Q. (2023). Direct C7‐H Arylation of Pyrazolo[1,5‐ a ]azines with Aryl Chlorides. Chemistry – A European Journal, 29(45). https://doi.org/10.1002/chem.202301485
Vancouver
Nguyen TVQ. Direct C7‐H Arylation of Pyrazolo[1,5‐ a ]azines with Aryl Chlorides. Chemistry – A European Journal. 2023;29(45). doi:10.1002/chem.202301485
BibTeX
@article{Nguyen2023,
author = {Nguyen, Thanh V Q},
title = {Direct C7‐H Arylation of Pyrazolo[1,5‐ a ]azines with Aryl Chlorides},
journal = {Chemistry – A European Journal},
year = {2023},
volume = {29},
number = {45},
doi = {10.1002/chem.202301485}
}
EUVIMED